Sign up to create alerts for Instruments,
Economic Events and content by followed authors
Free Sign Up Already have an account? Sign In
Al Gore
Sep 02, 2021 4:25PM ET
lol they need more fundings
0
0
Quotes
All Instrument Types
- All Instrument Types
- Indices
- Equities
- ETFs
- Funds
- Commodities
- Currencies
- Crypto
- Bonds
- Certificates
Please try another search
💎 Access the Market Tools Trusted by Thousands of Investors Get Started
U.S. to invest $3 billion in COVID-19 vaccine supply chain -White House official
Published Sep 02, 2021 03:32PM ET
Updated Sep 02, 2021 04:31PM ET
© Reuters. FILE PHOTO: Vials labelled "Moderna, Johnson & Johnson, Pfizer-BioNTech coronavirus disease (COVID-19) vaccine" are seen in this illustration picture taken May 2, 2021. REUTERS/Dado Ruvic
By Carl O'Donnell and Lisa Lambert
(Reuters) -The U.S. plans to invest $3 billion in the vaccine supply chain as it continues to work to position itself as a leading supplier of vaccines for the world, a top U.S. health official said on Thursday.
The funding, which will begin to be distributed in the coming weeks, will focus on manufacturers of the inputs used in COVID-19 vaccine production as well as facilities that fill and package vaccine vials, White House COVID adviser Jeffrey Zients said during a news conference.
"The investments we are making, the $3 billion, are in U.S. companies that will expand their capacity for critical supplies," Zients said.
He added that areas of focus will include lipids, bioreactor bags, tubing, needles, syringes, and personal protective equipment. The White House has not yet selected specific companies to receive the funds.
U.S. demand for COVID-19 vaccines remains high as the White House prepares to begin offering a third booster shot to Americans later this month, pending a regulator greenlight. The United States also plans to give hundreds of millions of shots to other countries during the remainder of the year.
Top U.S. infectious disease expert Anthony Fauci added that he would not be surprised if a third dose became standard for COVID-19 vaccines that originally were expected to require two shots.
U.S. cases of COVID-19 have surged to a seven-day average of more than 150,000 per day, up from less than 10,000 in June, according to federal data, as the contagious new Delta variant continues to circulate.
The daily average of COVID-19 deaths has risen this week to more than 950 from around 900 last week, U.S. Centers for Disease Control and Prevention Director Rochelle Walensky said.
Fauci downplayed concerns about a new COVID-19 variant known as Mu, or B.1.621, that some scientists are concerned could be resistant to vaccines.
"Even when you have variants that do diminish somewhat the efficacy of vaccines, the vaccines still are quite effective against variants of that type," Fauci said.
Related Articles
Comments (1)
Add Chart to Comment
Confirm Block
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
Report this comment
I feel that this comment is:
Comment flagged
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.